Impact of treatment on other patient-reported outcomes
| Relative per cent change from baseline in median patient-reported outcome | DR prednisone/ DMARD | Placebo/DMARD | Treatment difference (95% CI) | p Value |
|---|---|---|---|---|
| Days with recurrence of joint stiffness | −27.0 | −7.1 | −19.9 (−37.7 to −2.1) | 0.03 |
| Pain during the day (100 mm VAS) | −25.5 | −31.7 | −6.14 (−37.8 to 50.1) | 0.78 |
| Patient global assessment | −17.8 | 7.49 | −25.3 (−44.6 to −5.9) | 0.01 |
| Days with analgesic use | −18.7 | 1.9 | −20.6 (−37.3 to −4.0) | 0.02 |
DMARD, disease-modifying antirheumatic drug; DR, delayed-release; VAS, visual analogue scale.